Benzinga | Nov 3, 2021 05:23PM EDT

Lexicon Pharmaceuticals Q3 EPS $(0.16) Beats $(0.18) Estimate, Sales $23.00K Down From $6.63M YoY

Lexicon Pharmaceuticals (NASDAQ:LXRX) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.18) by 11.11 percent. This is a 62.79 percent increase over losses of $(0.43) per share from the same period last year. The company reported $23.00 thousand in sales this quarter. This is a 99.65 percent decrease over sales of $6.63 million the same period last year.